Chronic Subdural Hematoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. The subjects voluntarily joined this study and signed an informed consent form; 2. Age = 18 years old and = 85 years old, regardless of gender; 3. Confirmed as chronic subdural hematoma through cranial CT or MRI examination.
Exclusion criteria
Exclusion criteria: 1. Received treatment with traditional Chinese medicine or statins for promoting blood circulation and resolving stasis within two weeks before enrollment; 2. Allergy to the drugs used in this study; 3. Being treated with anticoagulant, antiplatelet, and thrombolytic drugs; 4. Individuals with severe diseases such as hematopoietic system, liver, kidney, heart, and coagulation function: 5. Have a history of spontaneous cerebral hemorrhage, traumatic cerebral hemorrhage, and other intracranial hemorrhage diseases; 6. The subject is unable to cooperate with the examination or follow-up (unable to cooperate with the physical examination and complete relevant examinations Check, including rating scales related to this topic); 7. Pregnant and lactating women; 8. According to the researcher's judgment, the clinical study cannot be completed due to other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CSDH hematoma volume;Recurrence time of CSDH; | — |
Secondary
| Measure | Time frame |
|---|---|
| Karnofsky (KPS) functional status score;NDS (Clinical Neurological Deficiency) Score;Barthel Index (Life Ability Score);MMSE (Cognitive Function) Score; | — |
Countries
China
Contacts
Affiliated Hospital of Shaanxi University of Chinese Medicine